Home | Welcome to Contract Pharma   
Last Updated Sunday, March 1 2015

Print

Topics - Drug Development


Refine by Date:
From: To:
Published February 27, 2015
New drug company launched by former CEO of Retrophin Read More »
Published February 26, 2015
Gains Phase IIa antiviral candidate AP611074 Read More »
Published February 26, 2015
Gains two late-stage assets, Dermadexin and Pruridexin Read More »
Published February 25, 2015
Opens newly expanded office Read More »
Published February 25, 2015
Smith to succeed Ackerman, Hickey takes on Global Discovery Services Read More »
Published February 24, 2015
Revenues up 29% in the quarter Read More »
Published February 24, 2015
Gains Phase III drug for gastrointestinal disease Read More »
Published February 23, 2015
Will develop TGF beta receptor kinase inhibitors Read More »
Published February 23, 2015
Merck to purchase 15% equity stake in NGM Read More »
Published February 23, 2015
Expands immuno-oncology pipeline Read More »
Published February 23, 2015
Secures long-term lease in Bannockburn, IL Read More »
Published February 23, 2015
Gains leading gastrointestinal franchise Read More »
Published February 20, 2015
To use TBK1 to study ALS disease mechanisms and screen for drug candidates Read More »
Published February 20, 2015
Adds corporate affairs and corporate development functions Read More »
Published February 20, 2015
AMPLEX and PREFIX are ready for Phase III Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On